Work

P-012 Safety and efficacy of standard of care (SOC) teclistamab (TEC) in patients with relapsed/ refractory multiple myeloma (RRMM), a single center experience

Year: 2023

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(23)01630-0

Authors: Ariel Grajales-Cruz, Sushmita Khadka, Brandon Blue, Doris Hansen, Omar Castaneda Puglianini, Ciara Freeman, Gabriel De Avila, Leonel Ochoa-Bayona, Hien Liu, Taiga Nishihori, Frederick Locke, Ken Shain, Rachid Baz, Melissa Alsina

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387004092

Cites:

Cited by: 1

Related to: 10